Navigation Links
Alcohol Injections to Tolerate Mortons Neuroma

According to a recent study conducted by researchers at the Royal National Orthopaedic Hospital and Kingston Hospital NHS Trust in Middlesex, United Kingdom. alcohol injections has a high success rate and is well tolerated by patients with Mortons neuroma, a common cause of foot pain.

Mortons neuroma is a growth of nerve tissue that occurs in a nerve in your foot, often between your third and fourth toes and usually causes a sharp, burning pain in the ball of your foot. For this study, researchers assessed the efficacy of a series of alcohol injections into the lesion.

I felt many patients with Mortons neuroma were undergoing an operation that was unnecessary and that the neuroma could be successfully treated in a less invasive manner, said David Connell, MD, lead author of the study.

The study consisted of 101 patients with Mortons neuroma. An average of 4.1 treatments per person were administered, and follow-up images were obtained at a mean of 21.1 months after the last treatment.

According to the study, there was a technical success rate of 100%. In 94% of the patients, partial or total symptom improvement was reported, with 84% becoming totally pain free. Thirty patients underwent sonography at six months after the last injection and showed a 30% decrease in the size of the neuroma.

Surprisingly, most patients maintain innervation to the toes despite the alcohol ablation, said Dr. Connell. This means that they dont have the permanent numbness and loss of sensation that accompanies resection of the nerve at surgery, he said.


'"/>




Page: 1

Related medicine news :

1. Alcohol shrinks brain
2. Alcohol linked to brain activity
3. Alcohol within the body
4. Alcoholism Drug Fails To Prevent Drinking Relapses
5. Alcoholics are prone to disability
6. Alcohol decreases risk of dementia
7. Alcohol injures stress hormone response
8. Role of wives of Alcoholics
9. Antiseizure Drug in help for Alcoholics
10. Alcohol is no tonic for sleep
11. Alcohol and Sun Don’t Mi
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/28/2017)... ... ... American Farmer proudly announces the participation of Pure Line Seeds, Inc (Pure Line ... fourth quarter 2017. American Farmer airs Tuesdays at 8:30aET on RFD-TV. , Founded in ... demand grew, the small company located in Moscow, Idaho extended its sales from Northern ...
(Date:6/28/2017)... ... June 28, 2017 , ... Designers Insurance Agency, a ... northern Virginia and DC, is announcing a cooperative charity event in conjunction with ... other disorders that lead to memory impairment. , The Insight Memory Care Center ...
(Date:6/27/2017)... ... June 27, 2017 , ... Harbour , a DAO (decentralized autonomous ... Ethereum blockchain, has released their technical specifications . , 2017 has seen an ... systematic approach for determining which offerings will garner the greatest ROI. Dean Eigenmann, Co-founder ...
(Date:6/27/2017)... ... 2017 , ... A January 18th article on medGadget reports that ... by the year 2024 according to a new report. The article also notes that ... titanium. Los Angeles area clinic Beverly Hills Periodontics & Dental Implant Center says that ...
(Date:6/27/2017)... , ... June 27, 2017 , ... ... Fabrykiewicz Scholarship Foundation Fundraiser hygiene symposium in Mystic, CT. Covering the process and ... offered their experience in these popular periodontal procedures. Drs. Toback and Urbanski practice ...
Breaking Medicine News(10 mins):
(Date:6/19/2017)... HORSHAM, Pa. , June 19, 2017  Researchers ... announced today that they will host a live, complimentary ... Perspectives from the benchtop to the real world" on ... PM EDT. This webinar will feature ... a rare look into the manipulation techniques abusers use ...
(Date:6/14/2017)... The Bio Supply Management Alliance (BSMA) has ... and the Biomedical Manufacturing Network to advance ... California by providing a platform for ... workforce development. The primary focus of this alliance is ... well as small and mid-sized biomedical companies. ...
(Date:6/11/2017)... June 10, 2017  Eli Lilly and Company (NYSE: ... Phase 3 studies of galcanezumab, an investigational treatment for ... data on several key secondary endpoints for galcanezumab compared ... these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented ... meeting in Boston . ...
Breaking Medicine Technology: